HOPE Research Institute

Welcome


HOPE Research Institute is an independent, multi-specialty, research organization dedicated to conducting clinical research trials in partnership with Valley physicians and their patients.

With NIH certified investigators and ACRP certified study coordinators, HOPE Research Institute can conduct inpatient and outpatient clinical trials across the Phoenix area.



AAHRPP Accreditation

Member of Hunt
AAHRPP

HOPE Research Institute, LLC, conducts clinical research projects for the pharmaceutical industry in the Valley of the Sun, Phoenix, Arizona. Under the careful supervision of trained, experienced physicians, Valley residents can participate in studies of investigational products. HOPE's research facility is conveniently located in North Phoenix on Union Hills Drive near the intersection of freeways 51 and 101. Participants are placed into studies in a variety of therapeutic areas, depending on their eligibility. HOPE's therapeutic ares include: Family / Internal Medicine, Gastroenterology, Neurology / Sleep Medicine, Ophthalmology, Orthopedics / Orthopedic Surgery, Pain Management, Podiatry, Urology, or Women's Health. Study participation can be a positive experience for both the physician and the patient that may provide opportunities for learning, healthcare, and the betterment of our society.

Health and Clinical Research - Latest Headlines

Food and Drug Administration--Press Releases

  • FDA approves generic versions of blood thinner Plavix - 17 May 2012The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
  • FDA expands use for FilmArray Respiratory Panel - 15 May 2012The U.S. Food and Drug Administration today expanded the use for the FilmArray Respiratory Panel, the first test that can simultaneously detect both viral and bacterial causes of respiratory infection from a single sample.
  • FDA issues alert on potential dangers of unproven treatment for multiple sclerosis - 10 May 2012The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called ?liberation therapy? or the ?liberation procedure? to treat chronic cerebrospinal venous insufficiency (CCSVI).
  • FDA proposal aims to help reduce unnecessary radiation exposure for children - 09 May 2012Today, the U.S. Food and Drug Administration announced that it is seeking public comment on a proposal encouraging manufacturers to consider the safety of children in the design of new X-ray imaging devices. In the draft guidance, FDA is recommending that manufacturers design new X-ray imaging devices with protocols and instructions that address use on pediatric patients.
  • FDA issues final rule on sterility testing of biological products - 03 May 2012The U.S. Food and Drug Administration issued its final rule on sterility testing, amending the requirements for most licensed biological products.

National Institutes of Health (NIH) News Releases

  • Optogenetics project takes top NIDA Addiction Science Award - 18 May 2012A project that maps dopamine circuits in the prefrontal cortex through optogenetic manipulation was given top honors in this year?s annual Addiction Science Awards at the 2012 Intel International Science and Engineering Fair (ISEF) -- the world's largest science competition for high school students. The awards were presented by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and Friends of NIDA, a coalition that supports NIDA?s mission. The Intel ISEF Addiction Science Awards were presented at a ceremony Thursday night at the David L. Lawrence Convention Center in Pittsburgh.
  • NIH-led study finds genetic test results do not trigger increased use of health services - 17 May 2012People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients? demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions.
  • NIH study finds that coffee drinkers have lower risk of death - 17 May 2012Older adults who drank coffee -- caffeinated or decaffeinated -- had a lower risk of death overall than others who did not drink coffee, according a study by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and AARP.
  • Paralyzed individuals use thought-controlled robotic arm to reach and grasp - 16 May 2012In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own -- for the first time in nearly 15 years -- by using her thoughts to direct a robotic arm. The trial, funded in part by the National Institutes of Health, is evaluating the safety and feasibility of an investigational device called the BrainGate neural interface system.

World Health Organization News

  • New data highlight increases in hypertension, diabetes incidence - 16 May 201216 May 2012 -- One in three adults worldwide has high blood pressure ? a condition that causes around half of all deaths from stroke and heart disease, according to the World health statistics 2012 report released today. One in 10 adults has diabetes.
  • WHO highlights importance of good hand hygiene for patient safety - 04 May 20124 May 2012 ? On Hand Hygiene Day (5 May), more than 15 000 health-care facilities from 156 countries are participating in the WHO Save Lives: Clean Your Hands Initiative by committing to improve patient safety by practicing better hand hygiene
  • 15 Million babies born too soon - 02 May 20122 May 2012 -- Over one million of preterm babies die shortly after birth and countless others suffer some type of lifelong physical, neurological, or educational disability. An estimated 75% of preterm babies who die could survive without expensive care if a few proven and inexpensive treatments and preventions were available worldwide.
  • World Malaria Day 2012 - 23 Apr 201224 April 2012 -- On the eve of World Malaria Day 2012, WHO hails global progress in combating malaria but highlights the need to further reinforce the fight. WHO?s new initiative, T3: Test, Treat, Track, urges malaria-endemic countries and donors to move towards universal access to diagnostic testing and antimalarial treatment, and to build robust malaria surveillance systems.